![Cellectis Nom Eo 05](/common/images/company/EU_ALCLS.png)
Cellectis nomme le docteur Adrian Kilcoyne directeur médical NEW YORK, 07 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de...
Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage...
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...
Cellectis publie ses résultats financiers du deuxième trimestre 2024 Statuts de médicament orphelin et de médicament pour une maladie pédiatrique rare accordés par la FDA et statut de médicament...
Cellectis Provides Financial Results for the Second Quarter 2024 ODD and RPDD granted by the FDA and ODD granted by the European Commission to UCART22 for the treatment of ALLODD granted by the...
ODD and RPDD granted by the FDA and ODD granted by the European Commission to UCART22 for the treatment of ALLODD granted by the FDA to CLLS52 (alemtuzumab) for ALL treatmentCash position of $273...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05...
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority) PARIS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Listing...
FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: ...
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.22 | 11.9565217391 | 1.84 | 2.115 | 1.804 | 57850 | 1.99258267 | DE |
4 | 0.06 | 3 | 2 | 2.115 | 1.726 | 58131 | 1.95401554 | DE |
12 | -0.39 | -15.9183673469 | 2.45 | 2.55 | 1.634 | 74868 | 1.93219449 | DE |
26 | -0.504 | -19.6567862715 | 2.564 | 3.025 | 1.634 | 83450 | 2.2925185 | DE |
52 | 0.23 | 12.5683060109 | 1.83 | 3.44 | 0.888 | 174849 | 2.47263849 | DE |
156 | -8.77 | -80.9787626962 | 10.83 | 13.22 | 0.888 | 166529 | 3.33944341 | DE |
260 | -9.47 | -82.1335646141 | 11.53 | 28.15 | 0.888 | 141230 | 6.81372182 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.